{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T19:36:14Z","timestamp":1771875374537,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.pnpbp.2013.11.013","type":"journal-article","created":{"date-parts":[[2013,12,4]],"date-time":"2013-12-04T19:12:57Z","timestamp":1386184377000},"page":"44-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Assessment of safety, cardiovascular and subjective effects after intravenous cocaine and lofexidine"],"prefix":"10.1016","volume":"50","author":[{"suffix":"II","given":"R.","family":"De La Garza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.P.","family":"Galloway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.F.","family":"Newton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Mendelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.N.","family":"Haile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Dib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.Y.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.-Y.A.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"J.J.","family":"Mahoney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Mojsiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Lao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2013.11.013_bb0005","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.6278591","article-title":"Alpha 2-adrenoceptor-mediated hyperpolarization of locus coeruleus neurons: intracellular studies in vivo","volume":"215","author":"Aghajanian","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb0010","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/jps.21401","article-title":"Pharmacokinetics of lofexidine hydrochloride in healthy volunteers","volume":"98","author":"Al-Ghananeem","year":"2009","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb0015","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1460-9568.1994.tb00272.x","article-title":"Blockade of prefronto-cortical alpha 1-adrenergic receptors prevents locomotor hyperactivity induced by subcortical d-amphetamine injection","volume":"6","author":"Blanc","year":"1994","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb0020","doi-asserted-by":"crossref","first-page":"84S","DOI":"10.1016\/S0895-7061(00)00223-5","article-title":"Identification and characterization of I1 imidazoline receptors: their role in blood pressure regulation","volume":"13","author":"Bousquet","year":"2000","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb0025","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pbb.2007.11.003","article-title":"Effects on spontaneous and cocaine-induced behavior of pharmacological inhibition of noradrenergic and serotonergic systems","volume":"89","author":"Carey","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb0030","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1001\/archgenpsychiatry.2011.124","article-title":"Mirtazapine to reduce methamphetamine use: a randomized controlled trial","volume":"68","author":"Colfax","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb0035","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1080\/09595230801935672","article-title":"A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal","volume":"27","author":"Cruickshank","year":"2008","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb0040","author":"Cunningham"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb0045","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/syn.10023","article-title":"Critical role of alpha1-adrenergic receptors in acute and sensitized locomotor effects of d-amphetamine, cocaine, and GBR 12783: influence of preexposure conditions and pharmacological characteristics","volume":"43","author":"Drouin","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb0050","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0893-133X(99)00158-X","article-title":"Alpha-2 adrenergic receptor agonists block stress-induced reinstatement of cocaine seeking","volume":"23","author":"Erb","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(00)00639-7","article-title":"Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity","volume":"406","author":"Fleckenstein","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb0060","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1177\/0269881111430746","article-title":"Guanfacine effects on stress, drug craving and prefrontal activation in cocaine dependent individuals: preliminary findings","volume":"26","author":"Fox","year":"2012","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb0065","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1124\/mi.9.4.6","article-title":"Mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapse","volume":"9","author":"Gaval-Cruz","year":"2009","journal-title":"Mol Interv"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb0070","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11920-013-0415-y","article-title":"Pharmacotherapy for stimulant-related disorders","volume":"15","author":"Haile","year":"2013","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb0075","doi-asserted-by":"crossref","first-page":"e47702","DOI":"10.1371\/journal.pone.0047702","article-title":"The impact of disulfiram treatment on the reinforcing effects of cocaine: a randomized clinical trial","volume":"7","author":"Haile","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb0080","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.pharmthera.2012.01.010","article-title":"Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate","volume":"134","author":"Haile","year":"2012","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb0085","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0893-133X(01)00227-5","article-title":"Repeated lofexidine treatment attenuates stress-induced, but not drug cues-induced reinstatement of a heroin\u2013cocaine mixture (speedball) seeking in rats","volume":"25","author":"Highfield","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb0090","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00213-011-2230-7","article-title":"Clonidine blocks stress-induced craving in cocaine users","volume":"218","author":"Jobes","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb0095","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0165-1781(97)00127-3","article-title":"Effects of acute intravenous cocaine on cardiovascular function, human learning, and performance in cocaine addicts","volume":"77","author":"Johnson","year":"1998","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb0100","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.drugalcdep.2013.07.032","article-title":"Differential effects of acute and chronic treatment with the alpha2-adrenergic agonist, lofexidine, on cocaine self-administration in rhesus monkeys","volume":"133","author":"Kohut","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb0105","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0169-328X(00)00288-6","article-title":"Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity","volume":"87","author":"Miller","year":"2001","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb0110","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/00005344-198307000-00006","article-title":"Comparison of effects of guanfacine and clonidine on blood pressure, heart rate, urinary catecholamines, and cyclic nucleotides during and after administration to patients with mild to moderate hypertension","volume":"5","author":"Nami","year":"1983","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb0115","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.pbb.2005.07.012","article-title":"Cocaine and methamphetamine produce different patterns of subjective and cardiovascular effects","volume":"82","author":"Newton","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb0120","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.psychres.2009.11.011","article-title":"The angiotensin-converting enzyme inhibitor perindopril treatment alters cardiovascular and subjective effects of methamphetamine in humans","volume":"179","author":"Newton","year":"2009","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb0125","doi-asserted-by":"crossref","first-page":"e30854","DOI":"10.1371\/journal.pone.0030854","article-title":"Noradrenergic alpha(1) receptor antagonist treatment attenuates positive subjective effects of cocaine in humans: a randomized trial","volume":"7","author":"Newton","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb0130","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1101\/lm.298006","article-title":"Alpha2A-adrenoceptor stimulation improves prefrontal cortical regulation of behavior through inhibition of cAMP signaling in aging animals","volume":"13","author":"Ramos","year":"2006","journal-title":"Learn Mem"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb0135","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugalcdep.2011.05.015","article-title":"A double-blind, placebo-controlled assessment of the safety of potential interactions between intravenous cocaine, ethanol, and oral disulfiram","volume":"119","author":"Roache","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb0140","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3","article-title":"Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin","volume":"39","author":"Rothman","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb0145","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1038\/npp.2010.127","article-title":"Disulfiram attenuates drug-primed reinstatement of cocaine seeking via inhibition of dopamine beta-hydroxylase","volume":"35","author":"Schroeder","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb0150","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/npp.2012.267","article-title":"The selective dopamine beta-hydroxylase inhibitor nepicastat attenuates multiple aspects of cocaine-seeking behavior","volume":"38","author":"Schroeder","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb0155","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00213-006-0640-8","article-title":"Effects of lofexidine on stress-induced and cue-induced opioid craving and opioid abstinence rates: preliminary findings","volume":"190","author":"Sinha","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb0160","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0014-2999(85)90156-6","article-title":"Prazosin: effect on psychomotor-stimulant cues and locomotor activity in mice","volume":"116","author":"Snoddy","year":"1985","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb0165","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0091-3057(01)00482-8","article-title":"Intravenous cocaine increases plasma epinephrine and norepinephrine in humans","volume":"68","author":"Sofuoglu","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2013.11.013_bb0170","doi-asserted-by":"crossref","first-page":"165S","DOI":"10.1111\/j.1365-2125.1980.tb04925.x","article-title":"Central effects of guanfacine and clonidine during wakefulness and sleep in healthy subjects","volume":"10","author":"Spiegel","year":"1980","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb9000","series-title":"Results from the 2011 National Survey on drug use and health: summary of national findings","author":"Substance Abuse and Mental Health Services Administration","year":"2012"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb0175","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1517\/13543784.2013.836488","article-title":"Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications","volume":"22","author":"Verrico","year":"2013","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb0180","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/00004714-199412000-00005","article-title":"Fluoxetine alters the effects of intravenous cocaine in humans","volume":"14","author":"Walsh","year":"1994","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb0185","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/sj.npp.1301263","article-title":"There and back again: a tale of norepinephrine and drug addiction","volume":"32","author":"Weinshenker","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb0190","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.drugalcdep.2008.04.002","article-title":"A phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal","volume":"97","author":"Yu","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pnpbp.2013.11.013_bb0195","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.biopsych.2005.02.003","article-title":"Prazosin, an alpha-1 adrenergic antagonist, reduces cocaine-induced reinstatement of drug-seeking","volume":"57","author":"Zhang","year":"2005","journal-title":"Biol Psychiatry"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584613002662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584613002662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T10:25:41Z","timestamp":1538994341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584613002662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":40,"alternative-id":["S0278584613002662"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2013.11.013","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of safety, cardiovascular and subjective effects after intravenous cocaine and lofexidine","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2013.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}